treatment for treatment resistant depression - SportsID
Markets Insider: AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs The Healthy @Reader's Digest on MSN: Ketamine therapy: A medical doctor explains its use for treatment-resistant depression MedPage Today: Psilocybin Failed to Live Up to Hype for Treatment-Resistant Depression Psilocybin plus therapy missed the primary endpoint in a trial of treatment-resistant depression, but met some secondary endpoints. The results may have been due to expectancy bias, a known issue with ... Worsened blood circulation from autonomic dysfunction may contribute to depressive symptoms, offering a new avenue for treatment-resistant depression.
Understanding the Context
Patients with treatment-resistant depression who engaged in a single day of treatment with inhaled mebufotenin reported significant symptom improvements at 8 days and again at 6 months, according to ... Morning Overview on MSN: Deep brain stimulation is being tested as an option for treatment-resistant depression Deep brain stimulation is being tested as an option for treatment-resistant depression Researchers from the United Kingdom recently studied whether a ketogenic (keto) diet, low in carbs, could help adults with treatment-resistant depression. Depression is common in the United States, ... A Cleveland Clinic psychiatrist explains how ketamine therapy is transforming depression treatment—and why it works when other options fall short.
Image Gallery
Key Insights
AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) announced that patients in a mid-stage trial of its experimental depression treatment BPL-003 showed improvement within two days of a single dose, with ...